Dataset summary
| TF Name: | FOSL2 | Species: | Mus musculus |
| Cell-type/Tissue: | bone marrow-derived macrophages | Condition/Source: | Sex: male; Strain:C57Bl/6EiJ; Treatment: KLA for 1 hr; Source: thioglycollate elicited macrophage cells; |
| JASPAR ID: | MA0478.1 MA1130.1 MA1138.1 MA1144.1 | Collections: | Permissive Robust |
| References: | GEO GSE111854 GSM3041183 GTRD EXP058771 PUBMED 30679424 | ||
External links
Models for profile: MA0478.1
Models for profile: MA1130.1
Models for profile: MA1138.1
Statistical details
30 datasets found for the same TF (FOSL2) in other cell-types/tissues
| TF Name | Cell-line | Condition/Source | Collections | Species | Identifiers | JASPAR ID |
|---|---|---|---|---|---|---|
| FOSL2 | A549 (lung carcinoma) | 1 h with 0.02% Ethanol (Myers) | Permissive Robust | Homo sapiens | ENCSR000BQO | MA0478.1 |
| FOSL2 | A549 (lung carcinoma) | 100nM dexamethasone (CHEBI:41879) for 8 hour | Permissive Robust | Homo sapiens | ENCSR242EWU | MA0478.1 ... |
| FOSL2 | A549 (lung carcinoma) | 100nM dexamethasone (CHEBI:41879) for 3 hour | Permissive Robust | Homo sapiens | ENCSR103UVU | MA0478.1 ... |
| FOSL2 | A549 (lung carcinoma) | 100nM dexamethasone (CHEBI:41879) for 5 hour | Permissive Robust | Homo sapiens | ENCSR111ZXV | MA0478.1 ... |
| FOSL2 | A549 (lung carcinoma) | 1 h with 100 nM Dexamethasone (Myers) | Permissive Robust | Homo sapiens | ENCSR330IJE | MA0478.1 ... |
| FOSL2 | A549 (lung carcinoma) | 100nM dexamethasone (CHEBI:41879) for 6 hour | Permissive Robust | Homo sapiens | ENCSR535HFQ | MA0478.1 ... |
| FOSL2 | A549 (lung carcinoma) | 100nM dexamethasone (CHEBI:41879) for 7 hour | Permissive Robust | Homo sapiens | ENCSR900RUE | MA0478.1 ... |
| FOSL2 | A549 (lung carcinoma) | 100nM dexamethasone (CHEBI:41879) for 4 hour | Permissive Robust | Homo sapiens | ENCSR686HIU | MA0478.1 ... |
| FOSL2 | A549 (lung carcinoma) | 100nM dexamethasone (CHEBI:41879) for 30 minute | Permissive Robust | Homo sapiens | ENCSR775UFR | MA0478.1 ... |
| FOSL2 | A549 (lung carcinoma) | 100nM dexamethasone (CHEBI:41879) for 12 hour | Permissive Robust | Homo sapiens | ENCSR067XTW | MA0478.1 ... |
| FOSL2 | A549 (lung carcinoma) | 100nM dexamethasone (CHEBI:41879) for 10 hour | Permissive Robust | Homo sapiens | ENCSR563GCV | MA0478.1 ... |
| FOSL2 | A549 (lung carcinoma) | 100nM dexamethasone (CHEBI:41879) for 2 hour | Permissive Robust | Homo sapiens | ENCSR274WRI | MA0478.1 ... |
| FOSL2 | primary fibroblasts | Treatment: starved with 0.5% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J Age: E13.5-E14.5 | Permissive Robust | Mus musculus | GSE83295 ... | MA0478.1 ... |
| FOSL2 | primary fibroblasts | Treatment: starved with 0.5% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J Age: E13.5-E14.5 | Permissive Robust | Mus musculus | GSE83295 ... | MA0478.1 ... |
| FOSL2 | primary fibroblasts | Treatment: 90min stimulation with 15% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J Age: E13.5-E14.5 | Permissive Robust | Mus musculus | GSE83295 ... | MA0478.1 ... |
| FOSL2 | primary fibroblasts | Treatment: 90min stimulation with 15% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J Age: E13.5-E14.5 | Permissive Robust | Mus musculus | GSE83295 ... | MA0478.1 ... |
| FOSL2 | bone marrow-derived macrophages | Sex: male; Strain:C57Bl/6EiJ; Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; | Permissive Robust | Mus musculus | GSE111854 ... | MA0478.1 ... |
| FOSL2 | hFOB 1.19 (fetal osteoblast) | DIFF | Permissive Robust | Homo sapiens | GSE82295 | MA0478.1 |
| FOSL2 | HepG2 (hepatoblastoma) | Permissive Robust | Homo sapiens | ENCSR000BHP | MA0478.1 | |
| FOSL2 | MCF7 (Invasive ductal breast carcinoma) | Permissive Robust | Homo sapiens | ENCSR000BUI | MA0478.1 | |
| FOSL2 | SK-N-SH (neuroblastoma) | Permissive Robust | Homo sapiens | ENCSR000BVB | MA0478.1 | |
| FOSL2 | MCF7 (Invasive ductal breast carcinoma) | Permissive Robust | Homo sapiens | ENCSR546KCN | MA0478.1 | |
| FOSL2 | STHdhQ7 (striatal cells) | Permissive Robust | Mus musculus | GSE43429 ... | MA0478.1 ... | |
| FOSL2 | STHdhQ111 (striatal cells) | Permissive Robust | Mus musculus | GSE43429 ... | MA0478.1 ... | |
| FOSL2 | Th0-cells | Permissive Robust | Mus musculus | GSE40918 ... | MA0478.1 ... | |
| FOSL2 | Th17-cells | Permissive Robust | Mus musculus | GSE40918 ... | MA0478.1 ... | |
| FOSL2 | Th17-cells | Permissive Robust | Mus musculus | GSE40918 ... | MA0478.1 ... | |
| FOSL2 | A549 (lung carcinoma) | Permissive Robust | Homo sapiens | ENCSR593DGU | MA0478.1 ... | |
| FOSL2 | LPS141 (Dedifferentiated liposarcoma) | Permissive Robust | Homo sapiens | GSE111253 ... | MA0478.1 ... | |
| FOSL2 | hESC-1 (Embryonic stem cells) | Permissive Robust | Homo sapiens | GSE69539 | MA0478.1 |